CLINICAL TRIALS PROFILE FOR METVIXIA
✉ Email this page to a colleague
All Clinical Trials for METVIXIA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02392390 ↗ | Effects of Topical Dynamic Phototherapy on the Microbiota of Chronic Wounds | Completed | Centre Hospitalier Universitaire de Nīmes | N/A | 2015-10-01 | The main objective of this study is to estimate the change in the relative numbers of commensal or low virulence potential bacteria before and after one session TDP. |
NCT02511145 ↗ | Comparison of Mechanical Penetration Enhancers on Metvixia Skin Penetration | Completed | Galderma R&D | Phase 1 | 2014-02-01 | Exploratory, mono-center, randomized, intra-individual, controlled trial involving healthy volunteers to compare the effect on MAL penetration into the skin following various mechanical penetration enhancement techniques. |
NCT02799069 ↗ | Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy | Completed | Accovion GmbH | Phase 3 | 2008-04-01 | The aim of the study is to evaluate the non-inferiority of BF-200 ALA (Ameluz) in the treatment of actinic keratosis (AK) with photodynamic therapy (PDT) compared to Metvix. |
NCT02799069 ↗ | Evaluation of Safety and Efficacy of BF-200 ALA for the Treatment of Actinic Keratosis With Photodynamic Therapy | Completed | Biofrontera Bioscience GmbH | Phase 3 | 2008-04-01 | The aim of the study is to evaluate the non-inferiority of BF-200 ALA (Ameluz) in the treatment of actinic keratosis (AK) with photodynamic therapy (PDT) compared to Metvix. |
NCT05104099 ↗ | Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia | Not yet recruiting | Institut de Cancérologie de Lorraine | Phase 2 | 2021-11-01 | This study is a single-center propsective clinical trial to assess the ability of fluorescence techniques to mark high-grade vulvar intraepithelial neoplasias including high-grade vulvar squamous intraepithelial lesions and differentiated vulvar intraepithelial neoplasias following 3 hours Metvixia application. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for METVIXIA
Condition Name
Clinical Trial Locations for METVIXIA
Clinical Trial Progress for METVIXIA
Clinical Trial Phase
Clinical Trial Sponsors for METVIXIA
Sponsor Name